Risk of unprovoked seizures after discontinuation of antiseizure medication at discharge following acute symptomatic seizures
We found that unprovoked seizure risk may not differ significantly between ASyS patients receiving a brief ASM course during hospitalization and those treated for a longer duration after discharge. Although our findings need confirmation in larger studies, they underscore the need for investigating optimal ASM duration in this patient population.
Authors
- Nicolas R. Thompson (ORCID: https://orcid.org/0000-0002-8973-5219)
- Neishay Ayub (ORCID: https://orcid.org/0000-0001-5490-8776)
- MarieElena Byrnes (ORCID: https://orcid.org/0000-0002-2646-2735)
- Sahar F. Zafar (ORCID: https://orcid.org/0000-0001-5252-5376)
- Adithya Sivaraju (ORCID: https://orcid.org/0000-0002-6027-9205)
- Clio Rubiños (ORCID: https://orcid.org/0000-0002-1680-2302)
- Vineet Punia (ORCID: https://orcid.org/0000-0002-0552-6736)
Institutions
- University of North Carolina at Chapel Hill (US)
- Cleveland Clinic (US)
- Yale New Haven Hospital (US)
- Harvard University (US)
- Outcomes Research Consortium (US)
- Brown University (US)
- Rhode Island Hospital (US)
- Yale University (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1111/epi.18464
- Citations
- 1
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47